Xarelto Lawsuit Claims Include Increased Risk of Hemorrhagic Stroke

March 30, 2016 – – BloodThinnerHelp.com reports on analyses claiming the blood-thinning drug Xarelto puts patients at risk for hemorrhagic stroke (strokes caused by bleeding in the brain). Reports indicate that the drug may actually increase a user’s chance of a stroke even though it is one of the issues the drug is marketed to prevent. Johnson & Johnson and Bayer AG, the drug’s manufacturers, are facing thousands of lawsuits after patients using Xarelto claim that their use of the drug was directly related to the adverse side effects they experienced.

During a hemorrhagic stroke, a weakened blood vessel ruptures. There are two types of weakened blood vessels that usually cause those types of strokes, according to The American Stroke Association. Those weakened blood vessels include aneurysms, which is a region of the blood vessel that balloons outward, and an arteriovenous malformation, which is a cluster of abnormally formed blood vessels. Both can cause a blood vessel to rupture and lead to bleeding in the brain.

Xarelto was first introduced to the United States in 2011 when it was approved by the FDA for preventing blood clots and deep vein thrombosis in patients undergoing knee and hip replacements, atrial fibrillation, and for general use in reducing the recurrence of blood clots, and stent thrombosis in patients with acute coronary syndrome. Since then, thousands of lawsuits have been filed against the manufacturers by patients who claim that the drug caused negative side effects about which the companies failed to thoroughly inform them. Some of the side effects that plaintiffs have associated with the drug are gastrointestinal bleeding, brain hemorrhages, internal bleeding, rectal bleeding, pulmonary embolisms (blood clots in the lung), epidural hematoma, stroke, and heart attacks.

Lawsuits concerning Xarelto that have been filed federally have been consolidated into part of a multi-district litigation panel in Eastern Louisiana that has now reached 2,800 cases.

While those cases approach a trial date, Attorney Joseph Osborne is working to help those individuals who believe they have been affected negatively by the blood-thinning drug, Xarelto. Qualifying individuals will have the opportunity to explore their legal rights and may be entitled to substantial financial compensation. Osborne is currently offering free consultations to those individuals.

For more information or to ask questions about Xarelto, contact Attorney Joseph Osborne at (866) 425- 8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008960